Next Technology (NXTT) had the highest return between May 1, 2022 and September 30, 2022 by a US stock, returning 832,654.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Next Technology (NXTT) | 5/1/2022 - 9/30/2022 | 832,654.45% |
Heart Test Laboratories Inc Common Stock (HSCS) | 5/1/2022 - 9/30/2022 | 346,958.82% |
Lottery (SEGG) | 5/1/2022 - 9/30/2022 | 2,063.46% |
Rhythm Pharmaceuticals (RYTM) | 5/1/2022 - 9/30/2022 | 295.16% |
Terns Pharmaceuticals (TERN) | 5/1/2022 - 9/30/2022 | 265.84% |
Belite Bio Inc ADR (BLTE) | 5/1/2022 - 9/30/2022 | 265.07% |
AMTD Digital (HKD) | 5/1/2022 - 9/30/2022 | 260% |
Pliant Therapeutics (PLRX) | 5/1/2022 - 9/30/2022 | 259.55% |
China SXT Pharmaceuticals (SXTC) | 5/1/2022 - 9/30/2022 | 256.48% |
Biomea Fusion (BMEA) | 5/1/2022 - 9/30/2022 | 230.41% |
Amylyx Pharmaceuticals (AMLX) | 5/1/2022 - 9/30/2022 | 214.88% |
Alaunos Therapeutics (TCRT) | 5/1/2022 - 9/30/2022 | 207.14% |
Fujian Blue Hat Interactive Entertainment Technology (BHAT) | 5/1/2022 - 9/30/2022 | 196.71% |
TCTM Kids IT Education (VSA) | 5/1/2022 - 9/30/2022 | 192.86% |
Immuneering (IMRX) | 5/1/2022 - 9/30/2022 | 190.47% |
MMTEC (MTC) | 5/1/2022 - 9/30/2022 | 185.71% |
Altimmune (ALT) | 5/1/2022 - 9/30/2022 | 184.41% |
Heartbeam (BEAT) | 5/1/2022 - 9/30/2022 | 178.57% |
Entrada Therapeutics (TRDA) | 5/1/2022 - 9/30/2022 | 164.87% |
Acumen Pharmaceuticals (ABOS) | 5/1/2022 - 9/30/2022 | 162.57% |
Array Technologies (ARRY) | 5/1/2022 - 9/30/2022 | 154.29% |
XChange TECINC (XHG) | 5/1/2022 - 9/30/2022 | 149.46% |
Annexon (ANNX) | 5/1/2022 - 9/30/2022 | 144.27% |
Ventyx Biosciences (VTYX) | 5/1/2022 - 9/30/2022 | 144.13% |
Cogent Biosciences (COGT) | 5/1/2022 - 9/30/2022 | 135.33% |
